BIOMAT Database Logo BIOMAT Database Logo

Dopa decarboxylase: substrates, coenzyme, inhibitors. 1966

T L Sourkes

UI MeSH Term Description Entries
D003067 Coenzymes Small molecules that are required for the catalytic function of ENZYMES. Many VITAMINS are coenzymes. Coenzyme,Enzyme Cofactor,Cofactors, Enzyme,Enzyme Cofactors,Cofactor, Enzyme
D004296 Dopa Decarboxylase One of the AROMATIC-L-AMINO-ACID DECARBOXYLASES, this enzyme is responsible for the conversion of DOPA to DOPAMINE. It is of clinical importance in the treatment of Parkinson's disease. Decarboxylase, Dopa
D004798 Enzymes Biological molecules that possess catalytic activity. They may occur naturally or be synthetically created. Enzymes are usually proteins, however CATALYTIC RNA and CATALYTIC DNA molecules have also been identified. Biocatalyst,Enzyme,Biocatalysts

Related Publications

T L Sourkes
Dopa-decarboxylase inhibitors.
May 1973, Lancet (London, England),
T L Sourkes
Editorial: Dopa decarboxylase inhibitors.
November 1974, British medical journal,
T L Sourkes
Transaldimination induces coenzyme reorientation in pig kidney dopa decarboxylase.
January 1995, Biochimie,
T L Sourkes
Coenzyme analog inhibitors of apoglutamate decarboxylase.
March 1969, Biochemistry,
T L Sourkes
DOPA decarboxylase inhibition through the interaction of coenzyme and substrate.
May 1952, The Journal of biological chemistry,
T L Sourkes
[Dopa and decarboxylase inhibitors in Parkinson's disease].
February 1974, Ugeskrift for laeger,
T L Sourkes
Interaction of L-DOPA decarboxylase with substrates: a spectrophotometric study.
June 1975, FEBS letters,
T L Sourkes
Inhibition of pig kidney dopa decarboxylase by coenzyme-5-hydroxytryptophan adducts.
August 1984, Experientia,
T L Sourkes
Gout induced by L-dopa and decarboxylase inhibitors.
April 1976, Postgraduate medical journal,
T L Sourkes
DOPA decarboxylase.
July 1996, Movement disorders : official journal of the Movement Disorder Society,
Copied contents to your clipboard!